| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.00022 | 1 |